The Korean Journal of Clinical Laboratory Science : eISSN 2288-1662 / pISSN 1738-3544

Table. 2.

Table. 2.

Adjusted odd ratios for the risk of obesity according to combination of hsCRP and uric acid

hsCRPa Uric acidb Obesity (BMI≥25 kg/m2, N=6,042) Severe obesity(BMI≥30 kg/m2, N=934) Morbid obesity(BMI≥35 kg/m2, N=131)
OR P-value OR P-value OR P-value
Adjusted model 1c Low (N=12,568) Low (N=11,396) 1.00 (reference) <0.001 1.00 (reference) <0.001 1.00 (reference) <0.001
High (N=1,172) 2.17 (1.88∼2.89) 3.22 (2.40∼4.32) 3.91 (1.45∼10.55)
Moderate (N=3,407) Low (N=2,893) 2.61 (2.35∼2.89) 5.16 (4.21∼6.32) 11.17 (5.90∼21.16)
High (N=514) 5.69 (4.51∼7.18) 13.41 (9.96∼18.05) 27.00 (13.37∼54.48)
High (N=1,420) Low (N=1,179) 2.32 (1.99∼2.70) 7.34 (5.71∼9.43) 20.92 (10.41∼42.03)
High (N=241) 7.53 (5.37∼10.54) 25.09 (17.79∼35.38) 68.90 (32.30∼147.00)
Adjusted model 2d Low (N=12,568) Low (N=11,396) 1.00 (reference) <0.001 1.00 (reference) <0.001 1.00 (reference) <0.001
High (N=1,172) 1.55 (1.27∼1.89) 1.63 (1.17∼2.27) 1.59 (0.61∼4.13)
Moderate (N=3,407) Low (N=2,893) 1.71 (1.48∼1.98) 2.10 (1.67∼2.65) 3.03 (1.58∼5.82)
High (N=514) 2.16 (1.64∼2.85) 3.35 (2.40∼4.67) 4.70 (2.37∼9.34)
High (N=1,420) Low (N=1,179) 1.59 (1.31∼1.94) 3.41 (2.56∼4.54) 5.63 (2.63∼12.06)
High (N=241) 1.89 (1.15∼3.10) 5.04 (3.32∼7.65) 8.20 (3.74∼17.98)

aLow hsCRP was defined when 1.00 mg/L or less, moderate hsCRP was defined when 1.00∼3.00 mg/L was present, and high hsCRP was defined when 3.00 mg/L or more was present.

bFor premenopausal women, the low uric acid is 0.9∼5.7 mg/dL and the high uric acid is 5.8∼13.6 mg/dL. For men and postmenopausal women, the low uric acid is 0.9∼7.0 mg/dL and the high uric acid is 7.1∼13.6 mg/dL.

cCalculated by complex samples multiple logistic regression was applied, with adjusting for age, sex.

dCalculated by complex samples multiple logistic regression was applied, with adjusting for age, sex, education, household income, drinking status, smoking status, stress awareness, average sleep time, physical activity, elevated fasting glucose, hypertension, elevated triglyceride, reduced HDL cholesterol, abdominal obesity.

Abbreviations: See Table 1.

Korean J Clin Lab Sci 2021;53:342-52 https://doi.org/10.15324/kjcls.2021.53.4.342
© 2021 Korean J Clin Lab Sci